U.S. Markets closed

Read This Before You Buy Oceania Healthcare Limited (NZSE:OCA) Because Of Its P/E Ratio

Simply Wall St

This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a basic P/E ratio analysis to Oceania Healthcare Limited's (NZSE:OCA), to help you decide if the stock is worth further research. Looking at earnings over the last twelve months, Oceania Healthcare has a P/E ratio of 13.72. That is equivalent to an earnings yield of about 7.3%.

View our latest analysis for Oceania Healthcare

How Do I Calculate A Price To Earnings Ratio?

The formula for price to earnings is:

Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Or for Oceania Healthcare:

P/E of 13.72 = NZ$1.03 ÷ NZ$0.08 (Based on the trailing twelve months to May 2019.)

Is A High P/E Ratio Good?

The higher the P/E ratio, the higher the price tag of a business, relative to its trailing earnings. That isn't a good or a bad thing on its own, but a high P/E means that buyers have a higher opinion of the business's prospects, relative to stocks with a lower P/E.

Does Oceania Healthcare Have A Relatively High Or Low P/E For Its Industry?

We can get an indication of market expectations by looking at the P/E ratio. The image below shows that Oceania Healthcare has a lower P/E than the average (16.1) P/E for companies in the healthcare industry.

NZSE:OCA Price Estimation Relative to Market, September 29th 2019

This suggests that market participants think Oceania Healthcare will underperform other companies in its industry. While current expectations are low, the stock could be undervalued if the situation is better than the market assumes. You should delve deeper. I like to check if company insiders have been buying or selling.

How Growth Rates Impact P/E Ratios

Companies that shrink earnings per share quickly will rapidly decrease the 'E' in the equation. That means even if the current P/E is low, it will increase over time if the share price stays flat. So while a stock may look cheap based on past earnings, it could be expensive based on future earnings.

Oceania Healthcare saw earnings per share decrease by 41% last year. And it has shrunk its earnings per share by 20% per year over the last three years. This might lead to low expectations.

A Limitation: P/E Ratios Ignore Debt and Cash In The Bank

The 'Price' in P/E reflects the market capitalization of the company. In other words, it does not consider any debt or cash that the company may have on the balance sheet. Hypothetically, a company could reduce its future P/E ratio by spending its cash (or taking on debt) to achieve higher earnings.

Such expenditure might be good or bad, in the long term, but the point here is that the balance sheet is not reflected by this ratio.

How Does Oceania Healthcare's Debt Impact Its P/E Ratio?

Oceania Healthcare's net debt equates to 39% of its market capitalization. While it's worth keeping this in mind, it isn't a worry.

The Bottom Line On Oceania Healthcare's P/E Ratio

Oceania Healthcare's P/E is 13.7 which is below average (18.8) in the NZ market. The debt levels are not a major concern, but the lack of EPS growth is likely weighing on sentiment.

When the market is wrong about a stock, it gives savvy investors an opportunity. As value investor Benjamin Graham famously said, 'In the short run, the market is a voting machine but in the long run, it is a weighing machine. So this free visual report on analyst forecasts could hold the key to an excellent investment decision.

But note: Oceania Healthcare may not be the best stock to buy. So take a peek at this free list of interesting companies with strong recent earnings growth (and a P/E ratio below 20).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.